The potential role of N7-methylguanosine (m7G) in cancer

Y Luo, Y Yao, P Wu, X Zi, N Sun, J He - Journal of hematology & oncology, 2022 - Springer
Abstract N 7-methylguanosine (m7G), one of the most prevalent RNA modifications, has
recently attracted significant attention. The m7G modification actively participates in …

Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment

AT Ruffin, H Li, L Vujanovic, DP Zandberg… - Nature Reviews …, 2023 - nature.com
Targeted immunotherapy has improved patient survival in head and neck squamous cell
carcinoma (HNSCC), but less than 20% of patients produce a durable response to these …

[HTML][HTML] Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors

M Gormley, G Creaney, A Schache, K Ingarfield… - British Dental …, 2022 - nature.com
Introduction Head and neck cancer appears to be increasing in incidence, with potential
changes in aetiology proposed. This paper aims to provide a narrative overview of the …

Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III KEYNOTE-048 study

KJ Harrington, B Burtness, R Greil… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE Pembrolizumab and pembrolizumab-chemotherapy demonstrated efficacy in
recurrent/metastatic head and neck squamous cell carcinoma in KEYNOTE-048. Post hoc …

[HTML][HTML] A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration

H Chi, P Jiang, K Xu, Y Zhao, B Song, G Peng… - Frontiers in …, 2022 - frontiersin.org
Background: Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive
disease with a poor prognosis for advanced tumors. Anoikis play a key role in cancer …

Aberrant translation regulated by METTL1/WDR4‐mediated tRNA N7‐methylguanosine modification drives head and neck squamous cell carcinoma progression

J Chen, K Li, J Chen, X Wang, R Ling… - Cancer …, 2022 - Wiley Online Library
Background Cancer cells selectively promote the translation of oncogenic transcripts to
stimulate cancer progression. Although growing evidence has revealed that tRNA …

Nivolumab plus ipilimumab versus EXTREME regimen as first-line treatment for recurrent/metastatic squamous cell carcinoma of the head and neck: the final results of …

RI Haddad, K Harrington, M Tahara… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE CheckMate 651 (ClinicalTrials. gov identifier: NCT02741570) evaluated first-line
nivolumab plus ipilimumab versus EXTREME (cetuximab plus cisplatin/carboplatin plus …

The role of IL-6 in cancer cell invasiveness and metastasis—overview and therapeutic opportunities

M Rašková, L Lacina, Z Kejík, A Venhauerová… - Cells, 2022 - mdpi.com
Interleukin 6 (IL-6) belongs to a broad class of cytokines involved in the regulation of various
homeostatic and pathological processes. These activities range from regulating embryonic …

Photodynamic therapy in oral cancer: A review of clinical studies

SA Mosaddad, RA Namanloo, SS Aghili, P Maskani… - Medical Oncology, 2023 - Springer
A significant mortality rate is associated with oral cancer, particularly in cases of late-stage
diagnosis. Since the last decades, oral cancer survival rates have only gradually improved …

Inferring early genetic progression in cancers with unobtainable premalignant disease

I Leshchiner, EA Mroz, J Cha, D Rosebrock, O Spiro… - Nature Cancer, 2023 - nature.com
Abstract Analysis of premalignant tissue has identified the typical order of somatic events
leading to invasive tumors in several cancer types. For other cancers, premalignant tissue is …